Publicaciones en colaboración con investigadores/as de Universidade Do Porto (83)

2024

  1. Data quality review of the Brazilian nosocomial infections surveillance system

    Journal of Infection and Public Health, Vol. 17, Núm. 4, pp. 687-695

  2. Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study

    International Journal of Clinical Pharmacy, Vol. 46, Núm. 2, pp. 411-420

  3. Effects of inpatient creatinine testing frequency on acute kidney injury identification and staging: a historical cohort study

    International Journal of Clinical Pharmacy

  4. Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping

    Addiction Science and Clinical Practice, Vol. 19, Núm. 1

  5. Mapping the concept of health care integration: A lexicographic analysis of scientific literature

    Research in Social and Administrative Pharmacy, Vol. 20, Núm. 5, pp. 506-511

  6. Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one

    Revista Portuguesa de Cardiologia

  7. Theories, models and frameworks for health systems integration. A scoping review

    Health Policy, Vol. 141

  8. Variability in Drug Procurement within Group 1B of the Pharmaceutical Specialized Scheme in Brazil

    Ciencia e Saude Coletiva, Vol. 29, Núm. 1

2023

  1. A Universal Pharmacological-Based List of Drugs with Anticholinergic Activity

    Pharmaceutics, Vol. 15, Núm. 1

  2. Chemical Constituents, Anticancer and Anti-Proliferative Potential of Limonium Species: A Systematic Review

    Pharmaceuticals, Vol. 16, Núm. 2

  3. Comment on the article: “Peer review practices in academic medicine: how the example of orthopaedic surgery may help shift the paradigm?”

    International Orthopaedics

  4. Community pharmacy and primary health care - Types of integration and their applicability: A narrative review

    Research in Social and Administrative Pharmacy, Vol. 19, Núm. 3, pp. 414-431

  5. Correction: Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies (DARU Journal of Pharmaceutical Sciences, (2023), 31, 1, (51-68), 10.1007/s40199-023-00461-3)

    DARU, Journal of Pharmaceutical Sciences

  6. Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ

    International Journal of Clinical Pharmacy, Vol. 45, Núm. 4, pp. 999-1006

  7. Efficacy and safety of pharmacological interventions for managing sickle cell disease complications in children and adolescents: Systematic review with network meta-analysis

    Pediatric Blood and Cancer, Vol. 70, Núm. 6

  8. Efficacy and safety of pharmacological interventions for managing sickle cell disease in children and adolescents: protocol for a systematic review with network meta-analysis

    BMJ open, Vol. 13, Núm. 2, pp. e064872

  9. Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies

    DARU, Journal of Pharmaceutical Sciences, Vol. 31, Núm. 1, pp. 51-68

  10. Geographical variation in antimicrobial use and multiresistant pathogens in Brazilian intensive care units: a nationwide study

    Journal of Infection in Developing Countries, Vol. 17, Núm. 4, pp. 485-493

  11. Heterogeneity in protocols and outcomes to study the effect of renin-angiotensin system blockers in inflammatory bowel disease: A systematic review

    Fundamental and Clinical Pharmacology, Vol. 37, Núm. 6, pp. 1139-1152

  12. Improving the quality of publications in and advancing the entire paradigms of clinical and social pharmacy practice research: the Granada statements

    Journal de Pharmacie Clinique, Vol. 42, Núm. 2, pp. 53-60